These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

470 related articles for article (PubMed ID: 32808122)

  • 1. Therapeutic Strategies in the Development of Anti-viral Drugs and Vaccines Against SARS-CoV-2 Infection.
    Bhatti JS; Bhatti GK; Khullar N; Reddy AP; Reddy PH
    Mol Neurobiol; 2020 Nov; 57(11):4856-4877. PubMed ID: 32808122
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An evidence-based systematic review on emerging therapeutic and preventive strategies to treat novel coronavirus (SARS-CoV-2) during an outbreak scenario.
    Gudadappanavar AM; Benni J
    J Basic Clin Physiol Pharmacol; 2020 Sep; 31(6):. PubMed ID: 32924964
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug Discovery Strategies for SARS-CoV-2.
    Shyr ZA; Gorshkov K; Chen CZ; Zheng W
    J Pharmacol Exp Ther; 2020 Oct; 375(1):127-138. PubMed ID: 32723801
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current development of COVID-19 diagnostics, vaccines and therapeutics.
    Zhang N; Li C; Hu Y; Li K; Liang J; Wang L; Du L; Jiang S
    Microbes Infect; 2020; 22(6-7):231-235. PubMed ID: 32387332
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Consensus summary report for CEPI/BC March 12-13, 2020 meeting: Assessment of risk of disease enhancement with COVID-19 vaccines.
    Lambert PH; Ambrosino DM; Andersen SR; Baric RS; Black SB; Chen RT; Dekker CL; Didierlaurent AM; Graham BS; Martin SD; Molrine DC; Perlman S; Picard-Fraser PA; Pollard AJ; Qin C; Subbarao K; Cramer JP
    Vaccine; 2020 Jun; 38(31):4783-4791. PubMed ID: 32507409
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Emerging strategies on in silico drug development against COVID-19: challenges and opportunities.
    Yadav M; Dhagat S; Eswari JS
    Eur J Pharm Sci; 2020 Dec; 155():105522. PubMed ID: 32827661
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Coronavirus Vaccine: Light at the End of the Tunnel.
    Ella KM; Mohan VK
    Indian Pediatr; 2020 May; 57(5):407-410. PubMed ID: 32291382
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potential Antiviral Drugs for SARS-Cov-2 Treatment: Preclinical Findings and Ongoing Clinical Research.
    Bimonte S; Crispo A; Amore A; Celentano E; Cuomo A; Cascella M
    In Vivo; 2020 Jun; 34(3 Suppl):1597-1602. PubMed ID: 32503817
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kallikrein-kinin blockade in patients with COVID-19 to prevent acute respiratory distress syndrome.
    van de Veerdonk FL; Netea MG; van Deuren M; van der Meer JW; de Mast Q; Brüggemann RJ; van der Hoeven H
    Elife; 2020 Apr; 9():. PubMed ID: 32338605
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of a Fluorescence-Based, High-Throughput SARS-CoV-2 3CL
    Froggatt HM; Heaton BE; Heaton NS
    J Virol; 2020 Oct; 94(22):. PubMed ID: 32843534
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Long Road Toward COVID-19 Herd Immunity: Vaccine Platform Technologies and Mass Immunization Strategies.
    Frederiksen LSF; Zhang Y; Foged C; Thakur A
    Front Immunol; 2020; 11():1817. PubMed ID: 32793245
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Shedding Light on the Effect of Natural Anti-Herpesvirus Alkaloids on SARS-CoV-2: A Treatment Option for COVID-19.
    Hassan STS
    Viruses; 2020 Apr; 12(4):. PubMed ID: 32340120
    [TBL] [Abstract][Full Text] [Related]  

  • 13. COVID-19 Coronavirus spike protein analysis for synthetic vaccines, a peptidomimetic antagonist, and therapeutic drugs, and analysis of a proposed achilles' heel conserved region to minimize probability of escape mutations and drug resistance.
    Robson B
    Comput Biol Med; 2020 Jun; 121():103749. PubMed ID: 32568687
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular Investigation of SARS-CoV-2 Proteins and Their Interactions with Antiviral Drugs.
    Calligari P; Bobone S; Ricci G; Bocedi A
    Viruses; 2020 Apr; 12(4):. PubMed ID: 32295237
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SARS-CoV-2 pathophysiology and assessment of coronaviruses in CNS diseases with a focus on therapeutic targets.
    Vallamkondu J; John A; Wani WY; Ramadevi SP; Jella KK; Reddy PH; Kandimalla R
    Biochim Biophys Acta Mol Basis Dis; 2020 Oct; 1866(10):165889. PubMed ID: 32603829
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting the SphK-S1P-SIPR Pathway as a Potential Therapeutic Approach for COVID-19.
    McGowan EM; Haddadi N; Nassif NT; Lin Y
    Int J Mol Sci; 2020 Sep; 21(19):. PubMed ID: 33003377
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic Targets and Computational Approaches on Drug Development for COVID-19.
    Shanmugam A; Muralidharan N; Velmurugan D; Gromiha MM
    Curr Top Med Chem; 2020; 20(24):2210-2220. PubMed ID: 32648845
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Advances in Pathogenesis, Progression, Potential Targets and Targeted Therapeutic Strategies in SARS-CoV-2-Induced COVID-19.
    Zhou H; Ni WJ; Huang W; Wang Z; Cai M; Sun YC
    Front Immunol; 2022; 13():834942. PubMed ID: 35450063
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outbreak of COVID-19: A Detailed Overview and Its Consequences.
    Shivalkar S; Pingali MS; Verma A; Singh A; Singh V; Paital B; Das D; Varadwaj PK; Samanta SK
    Adv Exp Med Biol; 2021; 1353():23-45. PubMed ID: 35137366
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Pandemic of Coronavirus Disease 2019 (COVID-19).
    Rashid NN
    Curr Mol Med; 2022; 22(9):761-765. PubMed ID: 34789125
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.